Bristol-Myers Squibb Company News Headlines

BMY 
$58.52
*  
0.35
0.59%
Get BMY Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading BMY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Bristol-Myers Collaborates for Opdivo-Imbruvica Combo - Analyst Blog
10/14/2014 4:20:00 PM - Zacks.com


ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog
10/14/2014 4:05:00 PM - Zacks.com


Can Dividend Stock GlaxoSmithKline plc Bounce Back?
10/14/2014 12:09:05 PM - Motley Fool


3 Dividend Stocks to Buy If the Market Crashes
10/14/2014 8:14:02 AM - Motley Fool


Bristol-Myers, Pharmacyclics And Janssen Collaborate On OPDIVO And IMBRUVICA
10/13/2014 8:28:00 AM - RTT News


Is Exelixis, Inc. Stock a Bad News Buy?
10/13/2014 7:30:16 AM - Motley Fool


The Next Biotech Buyout Stock
10/10/2014 7:15:02 AM - Motley Fool


Can Arrowhead Research Corp. Stock Recover from Its Horrendous Drop?
10/9/2014 4:09:02 PM - Motley Fool


InsiderInsights.com Daily Round Up 10/8/14: OMN, ENTG, AVNW, AGCO
10/9/2014 2:39:00 PM - Seeking Alpha


Portola's New Factor Xa Antidote Could Help Drive Xarelto And Eliquis Sales
10/9/2014 11:49:00 AM - Seeking Alpha


Bristol-Myers Co Regroups; Hepatitis C Fight With Gilead Sciences Not Over
10/9/2014 11:03:02 AM - Motley Fool


Bristol-Myers Gives Up on US Approval of 2-Drug HCV Combo - Analyst Blog
10/8/2014 5:10:00 PM - Zacks.com


Bristol Myers Squibb Getting Close To Lung Cancer Approval For Nivolumab
10/8/2014 12:52:49 PM - Trefis


Called Strike 3 For Bristol-Myers Squibb: What This Says For Gilead And Its Competitors In The Hep C Market
10/8/2014 10:51:00 AM - Seeking Alpha


Bristol-Myers Tells Gilead Sciences, Inc. "You Win"
10/8/2014 10:05:02 AM - Motley Fool


Bristol-Myers Says Successfully Resolved All U.S. Patent Litigation On Efavirenz
10/8/2014 8:09:00 AM - RTT News


Novartis Collaborates with Bristol-Myers Squibb - Analyst Blog
10/7/2014 3:50:00 PM - Zacks.com


Swiss Stocks Tumble In Widespread Sell-off
10/7/2014 12:22:00 PM - RTT News


Rexahn's New Nanotechnology Patent Creates Next-Generation Docetaxel, Gemcitabine And Cisplatin
10/7/2014 10:01:00 AM - Seeking Alpha


XLV, AMGN, BMY, BIIB: ETF Inflow Alert
10/7/2014 9:55:07 AM - BNK Invest


U.S. Hot Stocks: Hot Stocks to Watch
10/7/2014 9:45:00 AM - Dow Jones Business News


Bristol-Myers Withdraws New Drug Application For Asunaprevir
10/7/2014 9:26:00 AM - RTT News


Bristol-Myers Withdraws NDA For Asunaprevir - Quick Facts
10/7/2014 8:47:00 AM - RTT News


Bristol-Myers Squibb Announces Collaboration To Evaluate Opdivo
10/6/2014 8:42:00 AM - RTT News


European Markets Tipped To Extend Gains
10/6/2014 2:32:00 AM - RTT News